Nakamoto Inc.

Financial Services

NASDAQ:NAKA · NASDAQ Global Market

Market Cap $4.15B Beta -0.90 P/E (TTM) -0.2

$4.32 -3.36%

-$0.15 today

52W Low $4.05High $679.20

Vol 0.25M · Avg 0.22M

EPS (TTM)-$18.22

Financial - Capital Markets

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-99.22%

Period High

$652.00

Period Low

$4.08

Latest

$4.32

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Agilon Health, Inc.

NYSE:AGL

$1.88B

DBV Technologies S.A.

NASDAQ:DBVT

$416.60M

Delcath Systems, Inc.

NASDAQ:DCTH

$404.59M

SOPHiA GENETICS S.A.

NASDAQ:SOPH

$349.74M

Simulations Plus, Inc.

NASDAQ:SLP

$329.75M

Amarin Corporation plc

NASDAQ:AMRN

$315.21M

Lyell Immunopharma, Inc.

NASDAQ:LYEL

$315.01M

Cellectis S.A.

NASDAQ:CLLS

$310.29M

Larimar Therapeutics, Inc.

NASDAQ:LRMR

$296.96M

Definitive Healthcare Corp.

NASDAQ:DH

$88.59M

What is the latest NAKA filing?

The latest filing shown is 8-K dated Jun 11, 2026.

How many recent filings does NAKA have?

Intrinsic Alpha currently shows 20 recent filings for NAKA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.